Shin Nippon Biomedical Laboratories, Ltd. (TYO:2395)
1,305.00
-17.00 (-1.29%)
Sep 11, 2026, 3:30 PM JST
TYO:2395 Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, TYO:2395 stock has a consensus rating of "Buy" and an average price target of ¥1,694. The average 1-year stock price forecast is 29.77% higher than the current stock price, while the lowest is ¥1,387 (+6.28%) and the highest is ¥2,000 (+53.26%).
Price Target: ¥1,694 (+29.77%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for TYO:2395 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Nomura No rating | Nomura | Hold Maintains ¥1,280 → ¥1,387 | Hold | Maintains | ¥1,280 → ¥1,387 | +6.28% | Aug 27, 2026 |
Unknown Analyst Tokai-Tokyo Securities No rating | Tokai-Tokyo Securities | Buy Maintains ¥2,000 | Buy | Maintains | ¥2,000 | +53.26% | May 26, 2026 |
Financial Forecast
Revenue This Year
38.48B
from 32.52B
Increased by 18.32%
Revenue Next Year
41.69B
from 38.48B
Increased by 8.34%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is JPY.